Differences in the gut microbiota in patients with IBD compared to healthy controls suggest that probiotics may be of help. This article takes an in-depth look into the rationale of using probiotics for IBD and summarizes the evidence from recent clinical guidelines for the use of probiotics in Crohn’s disease, ulcerative colitis and pouchitis.
Can probiotics aid in treating bacterial vaginosis and vulvovaginal candidiasis?
14 Jun 2023by Andreu Prados
Probiotics are commonly used in clinical practice for digestive ailments. Some clinical trials also support the use of specific probiotics, taken orally or vaginally, for restoring the vaginal microbiota and managing bacterial vaginosis and vulvovaginal candidiasis. Here’s what we know.
The translational potential of microbiome research for human health and disease: takeaways from the 2023 GMFH Summit
28 Apr 2023by Andreu Prados, Joël Doré
The 11th Gut Microbiota for Health World Summit focused on emerging gut microbiome-targeted treatments in digestive, immune and cardiometabolic health. This post highlights the major take-aways from the conference and explores how they might impact clinical practice in the foreseeable future.
Can probiotics have anti-inflammatory effects worth considering in chronic intestinal diseases?
28 Sep 2022by Andreu Prados
Inflammation has been involved in the onset of chronic diseases. Probiotics emerge as a potential dietary tool for managing those conditions, partly through their role in immune system modulation and the anti-inflammatory response. Find out what is known about the anti-inflammatory effects of probiotics and their potential applications at the bedside.
The brain-gut-microbiota axis involves different routes of communication and can be targeted to influence brain and behavior
20 May 2022by Andreu Prados
The gut-brain connection is largely shaped by the composition and function of gut-dwelling microbial communities. This review article addresses how the brain and gut communicate and considers potential psychobiotic therapies.
Probiotics with an anti-inflammatory effect may reduce abdominal pain and hours of hospitalization in adult patients with acute uncomplicated diverticulitis
19 Apr 2022by Andreu Prados
The involvement of the gut microbiota in diverticulitis is gaining interest. This article explores what we know so far about the role of the gut microbiota in diverticulitis and discusses two recent clinical trials on the role of probiotics in managing acute uncomplicated diverticulitis.
The first 1,000 days of life: the prominence of bifidobacteria for infants’ gut microbiota development and later health outcomes
4 Mar 2022by Konstantina Zafeiropoulou
The first 2-3 years of life are crucial for shaping childhood health. Amid others, the importance of early-life gut microbiota in infant’s development and later human health has been long speculated. In particular, bifidobacteria are playing an essential role in infant’s gut microbiota and immune system maturation that supports its probiotic use in that age span.
Gut microbiome research in 2021: a look back at the findings from the last 12 months
27 Dec 2021by Andreu Prados
As we look back, we can certainly say that 2021 has been a productive year for gut microbiome research. In this last post of the year, we bring you key articles from our blog and studies on major advances in the role of the gut microbiome in maintaining health and helping to manage gut and immune-related diseases. We will also look at the therapeutic potential of probiotics, prebiotics and postbiotics for your clinical practice.
Thoughts about next-generation probiotics & postbiotics
6 Dec 2021by Mary Ellen Sanders, Patrice D. Cani
This article updates what is known in the field and how next-generation probiotics and postbiotics might impact on clinical practice in the foreseeable future.
Fermented foods show potential in increasing gut microbial diversity and modulating immune responses
22 Nov 2021by Konstantina Zafeiropoulou
Fermented foods, such as yogurt, kefir, kimchi and kombucha, have gained increasing popularity on the market shelves and consumers’ basket. Scientists at Stanford University elucidate how fermented foods may alter gut microbiota profile and reduce inflammatory markers.
